Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

14 results
Display

A Case of Nodular Hepatic Involvement of Multiple Myeloma Mimicking Hypervascular Hepatocellular Carcinoma

Park WK, Chang JC, Lee HZ, Kim HJ, Choi JH, Gu MJ

  • KMID: 863126
  • Korean J Hepatol.
  • 2002 Dec;8(4):490-494.
Nodular hepatic involvement of multiple myeloma is very rare. We report a case of nodular hepatic involvement of multiple myeloma, mimicking hypervascular hepatocellular carcinoma.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Nonsecretory Multiple Myeloma with Atypical Imaging Features

Lee HY, Yoo SM, Song IS, Yu H, Lee JB, Shin JW, Park IW

Multiple myeloma usually shows homogeneous enhancement on contrast-enhanced Magnetic Resonance imaging (MRI), and is accompanied by a monoclonal gammopathy in serum or urine. We report a case of nonsecretory myeloma,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Multiple Myeloma Showing Marked Differences in Serum IgG Levels between Protein Electrophoresis and Turbidimetry

Shin JW, Park R, Choi TY

We report a case of multiple myeloma showing marked differences in serum Immunoglobulin G (IgG) levels between serum protein electrophoresis and turbidimetry. A 47-yr old man was admitted to our...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Cerebral Infarction in IgG Multiple Myeloma with Hyperviscosity

Park MS, Kim BC, Kim IK, Lee SH, Choi SM, Kim MK, Lee SS, Cho KH

Cerebral infarction is an uncommon complication in multiple myeloma with hyperviscosity. Serum hyperviscosity may cause a variety of clinical manifestations including bleeding from mucosal membranes, congestive heart failure, retinopathy, and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Correlation of Chromosomal Aberrations with Prognostic Markers in Multiple Myeloma Patients- A Single Institution Study

Lee JW, Lee JK, Hong YJ, Hong SI, Chang YH

BACKGROUND: Immunoglobulin heavy chain (IGH) gene rearrangement, 13q14 deletion and trisomy 1q are frequently observed in Korean patients with multiple myeloma. The purpose of our study was to analyze the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Serum Free Light Chains for Diagnosis and Follow-up of Multiple Myeloma

Jung S, Kim M, Lim J, Kim Y, Han K, Min CK, Min WS

BACKGROUND: Free light chain (FLC) is widely used to evaluate B-cell proliferative diseases. Herein, we estimated the clinical usefulness of serum FLC in multiple myeloma (MM). METHODS: Fifty-one patients were...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Central Nervous System Myelomatosis with Complex Chromosome Aberrations

Bang HI, Yoo JY, Kim KH, Park R, Shin JW, Choi TY, Lee SC, Park HS, Won JH

Involvement of the central nervous system is very uncommon in multiple myeloma, observed in approximately 1% of the multiple myeloma patients. We report a case of central nervous system myelomatosis...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Salivary-Type Amylase-Producing Multiple Myeloma Presenting as Mediastinal Plasmacytoma and Myelomatous Pleural Effusion

Ok SJ, Kim IS, Lee EY, Kang JE, Lee SM, Song MK

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Plasma Cell Myeloma Initially Presenting as Lung Cancer

Cho SY, Jeong JH, Lee WI, Lee J, Hong IK, Suh JT, Lee HJ, Yoon HJ, Park TS

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Analysis of Thrombopoietin and Clinical Parameters as a Marker for Disease Progression in Patients with Multiple Myeloma

Lee JJ, Kang SY, Lee WI

BACKGROUND: Multiple myeloma (MM) causes the suppression of hematopoiesis because of malignant cells in the bone marrow. Thrombopoietin (TPO) is regulated by a feedback mechanism with platelets. Recently, it was...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical Significance of Serum Osteopontin in Patients with Multiple Myeloma

Kang SY, Lee JJ, Lee WI

BACKGROUND: Angiogenesis and osteoclastogenesis are increased in the bone marrow of multiple myeloma (MM) patients in parallel with the tumor progression. Osteopontin (OPN) is a multifunctional protein that is...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Impact of Genetic Abnormalities on the Prognoses and Clinical Parameters of Patients with Multiple Myeloma

Jekarl DW, Min CK, Kwon A, Kim H, Chae H, Kim M, Lim J, Kim Y, Han K

BACKGROUND: We reviewed patients with multiple myeloma (MM) in order to assess the incidence of genetic abnormalities and their associations with clinical parameters, risk groups, and prognosis. METHODS: A total of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Abnormalities in Chromosomes 1q and 13 Independently Correlate With Factors of Poor Prognosis in Multiple Myeloma

Kim M, Ju YS, Lee EJ, Kang HJ, Kim HS, Cho HC, Kim HJ, Kim JA, Lee DS, Lee YK

BACKGROUND: We comprehensively profiled cytogenetic abnormalities in multiple myeloma (MM) and analyzed the relationship between cytogenetic abnormalities of undetermined prognostic significance and established prognostic factors. METHODS: The karyotype of 333 newly...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Adverse Prognostic Impact of Bone Marrow Microvessel Density in Multiple Myeloma

Lee N, Lee H, Moon SY, Sohn JY, Hwang SM, Yoon OJ, Youn HS, Eom HS, Kong SY

BACKGROUND: Angiogenesis is important for the proliferation and survival of multiple myeloma (MM) cells. Bone marrow (BM) microvessel density (MVD) is a useful marker of angiogenesis and is determined by...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr